Screening assays for tyrosine kinase inhibitors: A review.
Inhibitor screening assay
Non-receptor tyrosine kinases
Receptor tyrosine kinases
Tyrosine kinase
Journal
Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336
Informations de publication
Date de publication:
20 Jan 2023
20 Jan 2023
Historique:
received:
22
08
2022
revised:
13
11
2022
accepted:
14
11
2022
pubmed:
21
11
2022
medline:
30
11
2022
entrez:
20
11
2022
Statut:
ppublish
Résumé
Tyrosine kinases have been intensively investigated as drug targets for several decades, since they regulate many cellular processes including cell growth, differentiation, and proliferation. Indeed, the deregulation of tyrosine kinases has been confirmed to play a vital role in the pathophysiology of many diseases. During the last few years, varieties of techniques have been developed to search for new tyrosine kinase inhibitors for cancer therapy, such as traditional filtration binding assay, scintillation proximity assay and some high-throughput screening methods. In this review, we describe the basic rules, merits and demerits, and application of a number of general and advanced technologies. The purpose of this review is to provide an insight into the numerous assays to achieve the exploration of new tyrosine kinase inhibitors.
Identifiants
pubmed: 36403346
pii: S0731-7085(22)00587-8
doi: 10.1016/j.jpba.2022.115166
pii:
doi:
Substances chimiques
Protein-Tyrosine Kinases
EC 2.7.10.1
Protein Kinase Inhibitors
0
Tyrosine
42HK56048U
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
115166Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Editor of JPBA Virtual Special Issue, ZJ. J.